# COMPREHENSIVE CLINICAL TRIAL DATA ABSTRACTION FORM
## For Systematic Reviews, Meta-Analyses, and Network Meta-Analyses

---

## WORKSHEET 1: STUDY IDENTIFICATION & SCREENING

### Study Identification
- **Study_ID** (Primary Key - Unique identifier)
- **Review_ID** (Links to your review/project)
- **First_Author_Last_Name**
- **Publication_Year**
- **Study_Short_Name** (e.g., "PARADIGM-HF 2014")
- **Full_Citation** (AMA or Vancouver format)
- **PMID** (PubMed ID)
- **DOI**
- **Clinical_Trial_Registry_ID** (e.g., NCT number)
- **Secondary_Registry_IDs** (EudraCT, ISRCTN, etc.)

### Source Documentation
- **Publication_Type** (Primary publication | Secondary analysis | Abstract only | Trial registry | Unpublished | Other)
- **Data_Source** (Published paper | Trial registry | FDA documents | EMA documents | Manufacturer data | Author correspondence | Other)
- **Multiple_Publications** (Yes/No - are there multiple reports from same trial?)
- **Linked_Publication_IDs** (List other Study_IDs from same trial)
- **Date_Data_Extracted**
- **Extractor_Initials**
- **Second_Extractor_Initials** (for dual extraction)
- **Conflicts_Resolved_By**

### Screening & Eligibility
- **Screened_Title_Abstract** (Yes/No)
- **Screened_Full_Text** (Yes/No/Not needed)
- **Inclusion_Decision** (Include | Exclude | Pending)
- **Exclusion_Reason** (Wrong population | Wrong intervention | Wrong comparator | Wrong outcome | Wrong study design | Duplicate | Other)
- **Exclusion_Reason_Details**

---

## WORKSHEET 2: STUDY DESIGN & METHODS

### Study Design Classification
- **Study_Design_Primary** (RCT | Quasi-experimental | Cohort | Case-control | Cross-sectional | Case series | Other)
- **Study_Design_Specific** (Parallel group | Crossover | Cluster randomized | Factorial | Adaptive | Non-inferiority | Equivalence | Superiority | Pragmatic | Other)
- **Randomization_Method** (Computer-generated | Random number table | Coin toss | Not described | Non-randomized | N/A)
- **Allocation_Concealment** (Central allocation | Sealed envelopes | Pharmacy-controlled | Not described | No concealment | N/A)
- **Blinding_Participants** (Yes | No | Unclear | N/A)
- **Blinding_Personnel** (Yes | No | Unclear | N/A)
- **Blinding_Outcome_Assessors** (Yes | No | Unclear | N/A)
- **Blinding_Description** (Single-blind | Double-blind | Triple-blind | Open-label | Unclear)

### Trial Characteristics
- **Trial_Phase** (Phase I | Phase I/II | Phase II | Phase II/III | Phase III | Phase IV | Not applicable)
- **Multicenter** (Yes | No | Unclear)
- **Number_of_Centers**
- **Countries** (List all)
- **Number_of_Countries**
- **Geographic_Region** (North America | Europe | Asia | Latin America | Africa | Middle East | Oceania | Multi-regional)
- **Trial_Setting** (Inpatient | Outpatient | Primary care | Secondary care | Tertiary care | Community | Mixed | Other)

### Timeline
- **Recruitment_Start_Date**
- **Recruitment_End_Date**
- **Study_Start_Date**
- **Study_Completion_Date**
- **Primary_Completion_Date**
- **Follow_Up_Duration_Planned** (value and units)
- **Maximum_Follow_Up_Duration** (value and units)
- **Median_Follow_Up_Duration** (value and units)
- **Follow_Up_Completion_Rate** (%)

### Sample Size & Power
- **Target_Sample_Size**
- **Actual_Sample_Size_Enrolled**
- **Sample_Size_Analyzed_Primary**
- **Power_Calculation_Reported** (Yes | No)
- **Target_Power** (%)
- **Assumed_Effect_Size**
- **Alpha_Level**
- **Non_Inferiority_Margin** (if applicable)

---

## WORKSHEET 3: PARTICIPANT CHARACTERISTICS

### Eligibility Criteria
- **Population_Description**
- **Key_Inclusion_Criteria** (free text, detailed)
- **Key_Exclusion_Criteria** (free text, detailed)
- **Disease_Condition** (specific diagnosis)
- **Disease_Severity** (Mild | Moderate | Severe | Mixed | Not specified)
- **Disease_Stage** (Early | Advanced | Metastatic | Recurrent | Other)
- **Disease_Duration_Criteria** (inclusion criteria regarding disease duration)

### Demographics (Baseline - Total Population)
- **Total_N_Randomized**
- **Total_N_Analyzed**
- **Mean_Age** (years)
- **SD_Age**
- **Median_Age**
- **Age_Range_Min**
- **Age_Range_Max**
- **Age_Group** (Pediatric <18 | Adults 18-64 | Elderly ≥65 | Mixed)
- **Percent_Male**
- **Percent_Female**
- **Race_Ethnicity_Description** (free text)
- **Percent_White**
- **Percent_Black**
- **Percent_Asian**
- **Percent_Hispanic**
- **Percent_Other_Race**

### Clinical Characteristics (Baseline - Total Population)
- **Mean_Weight_kg**
- **SD_Weight**
- **Mean_BMI**
- **SD_BMI**
- **Mean_Disease_Duration_Years**
- **SD_Disease_Duration**
- **Disease_Severity_Distribution** (% in each severity category)
- **Comorbidities_Description** (free text)
- **Percent_Diabetes**
- **Percent_Hypertension**
- **Percent_Cardiovascular_Disease**
- **Percent_Renal_Disease**
- **Percent_Prior_Treatment**
- **Prior_Treatment_Description**
- **Concomitant_Medications_Description**

### Additional Baseline Characteristics
- **Key_Prognostic_Factor_1_Name**
- **Key_Prognostic_Factor_1_Value**
- **Key_Prognostic_Factor_2_Name**
- **Key_Prognostic_Factor_2_Value**
- **Key_Prognostic_Factor_3_Name**
- **Key_Prognostic_Factor_3_Value**
- **Baseline_Balance_Adequate** (Yes | No | Unclear - are groups balanced?)
- **Baseline_Imbalance_Description**

---

## WORKSHEET 4: INTERVENTIONS & COMPARATORS

### Instructions: Create one row per treatment arm
*Use separate rows for each arm; include Arm_Number to distinguish*

### Arm Identification
- **Study_ID** (Foreign key)
- **Arm_Number** (1, 2, 3, etc.)
- **Arm_Label** (Brief name: e.g., "Drug A High Dose")
- **Arm_Type** (Experimental | Active comparator | Placebo | No treatment | Standard care | Dose comparison)

### Intervention Details
- **Intervention_Category** (Drug | Biologic | Device | Surgery | Radiation | Behavioral | Dietary | Exercise | Combination | Other)
- **Generic_Name** (for drugs)
- **Brand_Name**
- **Drug_Class** (e.g., ACE inhibitor, SSRI)
- **Route_of_Administration** (Oral | IV | SC | IM | Topical | Inhalation | Other)
- **Formulation** (Tablet | Capsule | Solution | Suspension | Other)

### Dosing & Administration
- **Dose_Amount**
- **Dose_Unit** (mg | g | IU | Other)
- **Dose_Frequency** (Once daily | BID | TID | QID | PRN | Other)
- **Total_Daily_Dose**
- **Dose_Escalation** (Yes | No)
- **Dose_Escalation_Schedule**
- **Dose_Modification_Allowed** (Yes | No)
- **Dose_Modification_Criteria**
- **Treatment_Duration_Planned**
- **Treatment_Duration_Actual_Mean**
- **Treatment_Duration_Unit** (Days | Weeks | Months | Years)

### Administration Details
- **Administration_Instructions** (With food | Fasting | Specific timing)
- **Co_Interventions_Allowed** (Yes | No)
- **Co_Interventions_Description**
- **Background_Therapy_Required**
- **Background_Therapy_Description**

### Enrollment & Adherence
- **N_Allocated_to_Arm**
- **N_Received_Intervention**
- **N_Did_Not_Receive_Reason**
- **Adherence_Rate** (%)
- **Adherence_Measurement_Method**
- **N_Discontinued_Treatment**
- **Discontinuation_Reason_AE** (N and %)
- **Discontinuation_Reason_Lack_Efficacy** (N and %)
- **Discontinuation_Reason_Withdrawal** (N and %)
- **Discontinuation_Reason_Lost_Followup** (N and %)
- **Discontinuation_Reason_Death** (N and %)
- **Discontinuation_Reason_Other** (N and %)

---

## WORKSHEET 5: OUTCOMES DEFINITIONS

### Instructions: Create one row per outcome
*This defines WHAT was measured; results go in separate worksheet*

### Outcome Identification
- **Study_ID** (Foreign key)
- **Outcome_Number** (1, 2, 3, etc.)
- **Outcome_Name** (Short descriptor)
- **Outcome_Type** (Primary | Secondary | Exploratory | Safety | Post-hoc)
- **Outcome_Priority** (If multiple primary outcomes, specify co-primary or hierarchical)

### Outcome Measurement Details
- **Outcome_Domain** (Efficacy | Safety | Quality of life | Functional status | Biomarker | Patient-reported | Clinical event | Mortality | Hospitalization | Other)
- **Outcome_Definition** (Detailed description of how measured)
- **Measurement_Scale** (Continuous | Dichotomous | Ordinal | Count | Time-to-event | Other)
- **Data_Type** (Mean/SD | Median/IQR | N/% | Hazard ratio | Count/person-time | Change from baseline | Final value | Other)

### Measurement Instrument
- **Measurement_Tool** (Name of scale, instrument, lab test, etc.)
- **Tool_Validated** (Yes | No | Unclear)
- **Measurement_Range_Min**
- **Measurement_Range_Max**
- **Direction_Better** (Higher better | Lower better | N/A)
- **MCID** (Minimal clinically important difference, if known)
- **Measurement_Unit**

### Timing & Assessment
- **Assessment_Timepoints** (List all: baseline, week 4, week 12, etc.)
- **Primary_Timepoint** (Which timepoint was specified as primary?)
- **Assessor** (Physician | Patient | Laboratory | Independent committee | Other)
- **Blinding_of_Assessor** (Yes | No | Unclear)

### Event-Specific (for dichotomous outcomes)
- **Event_Definition** (Precise definition of what constitutes an event)
- **Adjudication** (Yes | No - was there an adjudication committee?)
- **Adjudication_Blinded** (Yes | No | Unclear)

### Composite Outcomes
- **Composite_Outcome** (Yes | No)
- **Composite_Components** (List all components)
- **Hierarchical_Composite** (Yes | No)

---

## WORKSHEET 6: RESULTS - CONTINUOUS OUTCOMES

### Instructions: One row per outcome per timepoint per comparison
*For continuous data (means, medians)*

### Identification
- **Study_ID** (Foreign key)
- **Outcome_Number** (Links to Worksheet 5)
- **Arm_Number** (Links to Worksheet 4)
- **Timepoint** (Baseline | Week 4 | Month 6 | End of treatment | etc.)
- **Time_from_Baseline** (numeric value)
- **Time_Unit** (Days | Weeks | Months | Years)

### Sample Size
- **N_Analyzed**
- **N_Missing**
- **Missing_Data_Reason**
- **ITT_Analysis** (Yes | No | Modified ITT)
- **Analysis_Population** (ITT | Per protocol | As treated | Safety | Other)

### Continuous Data - Mean/SD
- **Mean**
- **SD**
- **SE** (standard error, if SD not available)
- **95CI_Lower**
- **95CI_Upper**

### Continuous Data - Median/Range
- **Median**
- **IQR_25th**
- **IQR_75th**
- **Range_Min**
- **Range_Max**

### Change from Baseline (if reported separately)
- **Mean_Change_from_Baseline**
- **SD_Change**
- **SE_Change**
- **95CI_Change_Lower**
- **95CI_Change_Upper**

### Comparison Statistics (if reported)
- **Comparison_Arm** (Which arm was this compared to?)
- **Mean_Difference**
- **95CI_Difference_Lower**
- **95CI_Difference_Upper**
- **P_Value**
- **Statistical_Test** (t-test | ANOVA | Mann-Whitney | Other)
- **Adjusted_Analysis** (Yes | No)
- **Adjustment_Variables** (List covariates)

---

## WORKSHEET 7: RESULTS - DICHOTOMOUS OUTCOMES

### Instructions: One row per outcome per timepoint per arm
*For binary/categorical outcomes (events, proportions)*

### Identification
- **Study_ID** (Foreign key)
- **Outcome_Number** (Links to Worksheet 5)
- **Arm_Number** (Links to Worksheet 4)
- **Timepoint**
- **Time_from_Baseline**
- **Time_Unit**

### Sample Size & Events
- **N_Analyzed**
- **N_Events**
- **N_Non_Events**
- **Percent_Events**
- **95CI_Percent_Lower**
- **95CI_Percent_Upper**

### Comparison Statistics (if reported)
- **Comparison_Arm**
- **Risk_Ratio**
- **RR_95CI_Lower**
- **RR_95CI_Upper**
- **Odds_Ratio**
- **OR_95CI_Lower**
- **OR_95CI_Upper**
- **Risk_Difference**
- **RD_95CI_Lower**
- **RD_95CI_Upper**
- **P_Value**
- **Statistical_Test** (Chi-square | Fisher exact | Logistic regression | Other)
- **Adjusted_Analysis** (Yes | No)
- **Adjustment_Variables**

### Additional Metrics
- **NNT** (Number needed to treat)
- **NNT_95CI_Lower**
- **NNT_95CI_Upper**
- **NNH** (Number needed to harm, for safety outcomes)

---

## WORKSHEET 8: RESULTS - TIME-TO-EVENT OUTCOMES

### Instructions: One row per outcome per arm
*For survival analysis, time-to-event data*

### Identification
- **Study_ID** (Foreign key)
- **Outcome_Number** (Links to Worksheet 5)
- **Arm_Number** (Links to Worksheet 4)

### Sample Size & Events
- **N_Analyzed**
- **N_Events**
- **N_Censored**
- **Total_Person_Time**
- **Person_Time_Unit** (Person-years | Person-months | etc.)

### Survival Estimates
- **Median_Survival_Time**
- **Median_Survival_Unit**
- **Median_95CI_Lower**
- **Median_95CI_Upper**
- **Mean_Survival_Time** (if reported)

### Event Rates at Specific Timepoints
- **Timepoint_1** (e.g., 1 year)
- **Event_Free_Rate_Timepoint_1** (%)
- **95CI_EFR_T1_Lower**
- **95CI_EFR_T1_Upper**
- **Timepoint_2**
- **Event_Free_Rate_Timepoint_2** (%)
- **95CI_EFR_T2_Lower**
- **95CI_EFR_T2_Upper**

### Hazard Ratio (vs comparator)
- **Comparison_Arm**
- **Hazard_Ratio**
- **HR_95CI_Lower**
- **HR_95CI_Upper**
- **P_Value**
- **Log_Rank_P_Value**
- **Statistical_Method** (Cox regression | Kaplan-Meier | Other)
- **Proportional_Hazards_Assumption_Met** (Yes | No | Not tested)
- **Adjusted_Analysis** (Yes | No)
- **Adjustment_Variables**

---

## WORKSHEET 9: ADVERSE EVENTS & SAFETY

### Overall Safety Summary
- **Study_ID** (Foreign key)
- **Arm_Number** (Links to Worksheet 4)
- **Safety_Population_N**
- **Total_Person_Years_Exposure**

### Any Adverse Events
- **N_Any_AE**
- **Percent_Any_AE**
- **N_Serious_AE**
- **Percent_Serious_AE**
- **N_Discontinued_Due_to_AE**
- **Percent_Discontinued_Due_to_AE**
- **N_Deaths**
- **Percent_Deaths**
- **Deaths_Related_to_Treatment** (N)

### Specific Adverse Events (create multiple rows for each AE)
- **AE_Preferred_Term** (use MedDRA if available)
- **AE_System_Organ_Class**
- **AE_Severity** (Mild | Moderate | Severe | Grade 1-5)
- **AE_Seriousness** (Serious | Non-serious)
- **AE_Number_Events**
- **AE_Number_Patients**
- **AE_Percent_Patients**
- **AE_Relatedness** (Definitely related | Probably related | Possibly related | Unlikely related | Not related)
- **AE_Leading_to_Discontinuation** (N)
- **AE_Leading_to_Death** (N)

### Laboratory Abnormalities
- **Lab_Parameter** (e.g., ALT, Creatinine)
- **Lab_Abnormality_Definition** (e.g., >3x ULN)
- **N_Patients_Abnormality**
- **Percent_Patients_Abnormality**

---

## WORKSHEET 10: SUBGROUP ANALYSES

### Instructions: One row per subgroup per outcome
*Capture all pre-specified and post-hoc subgroup analyses*

### Identification
- **Study_ID** (Foreign key)
- **Outcome_Number** (Links to Worksheet 5)
- **Subgroup_Analysis_Number**

### Subgroup Definition
- **Subgroup_Variable** (Age | Sex | Race | Disease severity | Biomarker status | etc.)
- **Subgroup_Prespecified** (Yes | No - was this analysis planned a priori?)
- **Subgroup_Categories** (List all categories compared)

### Subgroup Results (for first category)
- **Subgroup_Category_1_Name** (e.g., "Age <65")
- **Subgroup_1_N**
- **Subgroup_1_Effect_Estimate** (could be OR, RR, MD, HR depending on outcome)
- **Subgroup_1_95CI_Lower**
- **Subgroup_1_95CI_Upper**

### Subgroup Results (for second category)
- **Subgroup_Category_2_Name** (e.g., "Age ≥65")
- **Subgroup_2_N**
- **Subgroup_2_Effect_Estimate**
- **Subgroup_2_95CI_Lower**
- **Subgroup_2_95CI_Upper**

### Interaction Test
- **Interaction_P_Value**
- **Interaction_Test_Method**
- **Interaction_Significant** (Yes | No - typically p<0.10)
- **Author_Interpretation_Subgroup_Effect**

### Additional Categories (if >2 subgroups)
- **Subgroup_Category_3_Name**
- **Subgroup_3_N**
- **Subgroup_3_Effect_Estimate**
- **Subgroup_3_95CI_Lower**
- **Subgroup_3_95CI_Upper**

---

## WORKSHEET 11: RISK OF BIAS ASSESSMENT

### Instructions: One row per study
*Following Cochrane Risk of Bias 2.0 (RoB 2) tool*

### Study Identification
- **Study_ID** (Foreign key)
- **RoB_Tool_Used** (RoB 2.0 | RoB 1.0 | Newcastle-Ottawa | ROBINS-I | Other)
- **RoB_Assessor_1**
- **RoB_Assessor_2**
- **Date_Assessed**

### RoB 2.0 Domains

#### Domain 1: Randomization Process
- **D1_Allocation_Sequence_Adequate** (Y | PY | PN | N | NI)
- **D1_Allocation_Concealment_Adequate** (Y | PY | PN | N | NI)
- **D1_Baseline_Imbalances** (Y | PY | PN | N | NI)
- **D1_Judgment** (Low | Some concerns | High)
- **D1_Support_for_Judgment** (free text)

#### Domain 2: Deviations from Intended Interventions
- **D2_Participants_Aware** (Y | PY | PN | N | NI)
- **D2_Carers_Aware** (Y | PY | PN | N | NI)
- **D2_Deviations_from_Protocol** (Y | PY | PN | N | NI)
- **D2_Deviations_Balanced** (Y | PY | PN | N | NI)
- **D2_Appropriate_Analysis** (Y | PY | PN | N | NI)
- **D2_Judgment** (Low | Some concerns | High)
- **D2_Support_for_Judgment**

#### Domain 3: Missing Outcome Data
- **D3_Data_Available_All_Participants** (Y | PY | PN | N | NI)
- **D3_Evidence_Result_Not_Biased** (Y | PY | PN | N | NI)
- **D3_Missingness_Could_Affect_Result** (Y | PY | PN | N | NI)
- **D3_Judgment** (Low | Some concerns | High)
- **D3_Support_for_Judgment**

#### Domain 4: Measurement of Outcome
- **D4_Outcome_Assessment_Appropriate** (Y | PY | PN | N | NI)
- **D4_Assessors_Blinded** (Y | PY | PN | N | NI)
- **D4_Assessment_Influenced_by_Knowledge** (Y | PY | PN | N | NI)
- **D4_Judgment** (Low | Some concerns | High)
- **D4_Support_for_Judgment**

#### Domain 5: Selection of Reported Result
- **D5_Data_Analyzed_Per_Protocol** (Y | PY | PN | N | NI)
- **D5_Multiple_Outcome_Measurements** (Y | PY | PN | N | NI)
- **D5_Multiple_Analyses** (Y | PY | PN | N | NI)
- **D5_Result_Selected_from_Multiple** (Y | PY | PN | N | NI)
- **D5_Judgment** (Low | Some concerns | High)
- **D5_Support_for_Judgment**

### Overall Risk of Bias
- **Overall_RoB_Judgment** (Low | Some concerns | High)
- **Overall_RoB_Justification**

### Additional Bias Concerns
- **Other_Bias_Detected** (Yes | No)
- **Other_Bias_Description**
- **Selective_Outcome_Reporting_Suspected** (Yes | No | Unclear)

---

## WORKSHEET 12: FUNDING & CONFLICTS OF INTEREST

### Study Identification
- **Study_ID** (Foreign key)

### Funding Sources
- **Funding_Source_Primary** (Industry | Government | Foundation | University | Mixed | Unfunded | Not reported)
- **Funding_Source_Details** (Specific sponsor name)
- **Industry_Sponsorship** (Yes | No | Unclear)
- **Manufacturer_Involved** (Yes | No | Unclear)
- **Manufacturer_Role** (Design | Conduct | Analysis | Interpretation | Writing | All | None)

### Author Conflicts
- **COI_Statement_Present** (Yes | No)
- **COI_Number_Authors_Declared**
- **COI_Financial_Industry** (Any author: Yes | No | Not reported)
- **COI_Employment_Industry** (Yes | No | Not reported)
- **COI_Consultant_Industry** (Yes | No | Not reported)
- **COI_Honoraria_Industry** (Yes | No | Not reported)
- **COI_Stock_Ownership** (Yes | No | Not reported)
- **COI_Research_Grants** (Yes | No | Not reported)
- **COI_Specifics** (free text details)

### Data Access & Analysis Independence
- **Academic_Authors_Had_Data_Access** (Yes | No | Unclear)
- **Independent_Statistical_Analysis** (Yes | No | Unclear)
- **Sponsor_Control_Over_Publication** (Yes | No | Unclear)

---

## WORKSHEET 13: GRADE QUALITY ASSESSMENT

### Instructions: One row per outcome per comparison
*For rating certainty/quality of evidence per GRADE*

### Identification
- **Study_ID** (Foreign key)
- **Outcome_Number** (Links to Worksheet 5)
- **Comparison** (Which treatment vs which comparator)

### Starting Level
- **Study_Design_Category** (RCT | Observational)
- **Starting_Quality** (High | Low - RCTs start high, observational starts low)

### GRADE Domains - Downgrading Factors

#### Risk of Bias
- **Risk_of_Bias_Serious** (Not serious | Serious | Very serious)
- **Risk_of_Bias_Reason**
- **Risk_of_Bias_Downgrade** (0 | -1 | -2)

#### Inconsistency
- **Inconsistency_Serious** (Not serious | Serious | Very serious)
- **Inconsistency_I2_Value** (%)
- **Inconsistency_Reason**
- **Inconsistency_Downgrade** (0 | -1 | -2)

#### Indirectness
- **Indirectness_Serious** (Not serious | Serious | Very serious)
- **Indirectness_Reason** (PICO elements differ from question of interest)
- **Indirectness_Downgrade** (0 | -1 | -2)

#### Imprecision
- **Imprecision_Serious** (Not serious | Serious | Very serious)
- **Imprecision_Reason** (Wide CI | Crosses threshold | Small N)
- **Imprecision_Downgrade** (0 | -1 | -2)

#### Publication Bias
- **Publication_Bias_Suspected** (Not suspected | Suspected | Strongly suspected)
- **Publication_Bias_Reason** (Asymmetric funnel plot | Missing studies | Industry sponsorship)
- **Publication_Bias_Downgrade** (0 | -1 | -2)

### GRADE Domains - Upgrading Factors (for observational studies)

#### Large Effect
- **Large_Effect** (None | Large RR>2 or <0.5 | Very large RR>5 or <0.2)
- **Large_Effect_Upgrade** (0 | +1 | +2)

#### Dose-Response
- **Dose_Response_Gradient** (None | Present)
- **Dose_Response_Upgrade** (0 | +1)

#### Confounding
- **All_Plausible_Confounding** (Would reduce effect | Would increase effect | Not applicable)
- **Confounding_Upgrade** (0 | +1)

### Final GRADE Rating
- **Total_Downgrade_Points**
- **Total_Upgrade_Points**
- **Final_Quality_Rating** (High | Moderate | Low | Very low)
- **Quality_Justification** (free text summary)

---

## WORKSHEET 14: NETWORK META-ANALYSIS SPECIFIC

### Instructions: Use when conducting network meta-analysis
*One row per study - captures geometry & connectivity*

### Network Characteristics
- **Study_ID** (Foreign key)
- **Number_of_Arms_in_Study**
- **Arms_in_Network** (List which arms contribute to network)
- **Direct_Comparisons_Provided** (List all pairwise comparisons, e.g., "A vs B, A vs C")
- **Multi_Arm_Study** (Yes | No - more than 2 arms?)

### Network Connectivity
- **Contributes_to_Loop** (Yes | No - is study part of closed loop?)
- **Loop_Description** (Which loop: e.g., "A-B-C-A")
- **Common_Comparator** (Which treatment is common comparator?)

### Transitivity Assessment
- **Patient_Population_Comparable** (Yes | No | Unclear)
- **Disease_Severity_Comparable** (Yes | No | Unclear)
- **Concomitant_Treatments_Comparable** (Yes | No | Unclear)
- **Study_Era_Comparable** (Yes | No | Unclear)
- **Effect_Modifiers_Present** (List potential effect modifiers)
- **Transitivity_Concern** (Low | Moderate | High)
- **Transitivity_Justification**

### Consistency Assessment (if direct and indirect evidence available)
- **Direct_Evidence_Available** (Yes | No)
- **Indirect_Evidence_Available** (Yes | No)
- **Node_Splitting_Performed** (Yes | No | N/A)
- **Node_Splitting_P_Value**
- **Consistency_Concern** (No inconsistency | Inconsistency suspected | Inconsistency confirmed)

---

## WORKSHEET 15: ADDITIONAL DATA & NOTES

### Economic Data (if reported)
- **Study_ID** (Foreign key)
- **Cost_Analysis_Included** (Yes | No)
- **Healthcare_Costs_Reported** (Yes | No)
- **Cost_Currency**
- **Cost_Year**
- **Cost_Per_Patient_Treatment_Arm_1**
- **Cost_Per_Patient_Treatment_Arm_2**
- **QALY_Reported** (Yes | No)
- **ICER_Reported** (Yes | No)
- **ICER_Value**

### Patient-Reported Outcomes
- **PRO_Instruments_Used** (List all: SF-36, EQ-5D, etc.)
- **Quality_of_Life_Data_Available** (Yes | No)
- **Patient_Satisfaction_Reported** (Yes | No)
- **Patient_Preference_Reported** (Yes | No)

### Additional Analyses
- **Sensitivity_Analyses_Performed** (Yes | No)
- **Sensitivity_Analysis_Description**
- **Per_Protocol_Analysis** (Yes | No)
- **As_Treated_Analysis** (Yes | No)
- **Completer_Analysis** (Yes | No)
- **Imputation_Method** (None | LOCF | BOCF | Multiple imputation | Other)

### Data Quality & Completeness
- **Data_Extraction_Confidence** (High | Moderate | Low)
- **Data_Extraction_Challenges** (free text)
- **Missing_Data_Reported** (Completely | Partially | Not reported)
- **Need_Author_Contact** (Yes | No)
- **Author_Contact_Date**
- **Author_Response_Received** (Yes | No | Pending)
- **Additional_Data_Obtained** (Yes | No)

### General Notes
- **Important_Study_Limitations** (free text)
- **Unique_Study_Features** (free text)
- **Concerns_for_Meta_Analysis** (free text)
- **Data_Suitable_for_Pooling** (Yes | No | Uncertain)
- **Extractor_Comments** (free text)
- **Review_Team_Discussion_Notes** (free text)

---

## DATA DICTIONARY NOTES

### Field Coding Conventions:
- **Y** = Yes
- **N** = No  
- **PY** = Probably yes
- **PN** = Probably no
- **NI** = No information
- **N/A** = Not applicable
- **Unclear** = Information not clearly reported

### Date Format: 
Use ISO 8601 (YYYY-MM-DD) or YYYY-MM or YYYY depending on precision available

### Multiple Values:
When a field can have multiple values (e.g., multiple countries, multiple comorbidities), use semicolon (;) to separate

### Missing Data Codes:
- **NR** = Not reported
- **NA** = Not applicable
- **ND** = Not done
- **UC** = Unclear from report

---

## RECOMMENDED EXCEL STRUCTURE

### Sheet Organization:
1. Create separate worksheets for each section above
2. Use first row for field names (headers)
3. Use Data Validation dropdowns for categorical fields
4. Consider freezing header row for easy scrolling
5. Use conditional formatting to highlight missing critical data

### Key Fields Across Worksheets:
- **Study_ID** should be consistent across all worksheets (acts as foreign key)
- Use **Arm_Number** and **Outcome_Number** to link related data
- Consider color-coding worksheets by category (design=blue, results=green, quality=red)

### Data Entry Tips:
1. Extract to paper form first, then enter into Excel
2. Dual extraction for critical fields
3. Regular consensus meetings for discrepancies
4. Version control for the database
5. Regular backups
6. Audit trail of changes

---

## QUALITY CHECKS

### Before Analysis, Verify:
- [ ] Study_ID is unique for each study
- [ ] All studies have Risk of Bias assessment
- [ ] Primary outcome clearly identified
- [ ] Sample sizes reconcile across worksheets
- [ ] Effect estimates have confidence intervals
- [ ] Statistical tests are appropriate for data type
- [ ] Units are consistently recorded
- [ ] No duplicate data entry
- [ ] All critical fields populated (mark what's "critical" for your review)

---

*This form follows PRISMA 2020, Cochrane Handbook standards, GRADE approach, and accommodates network meta-analysis requirements. Customize based on your specific therapeutic area and research question.*